| Literature DB >> 26538322 |
Susanne Wegmann1, Eduardo A Maury1, Molly J Kirk1, Lubna Saqran1, Allyson Roe1, Sarah L DeVos1, Samantha Nicholls1, Zhanyun Fan1, Shuko Takeda1, Ozge Cagsal-Getkin1, Christopher M William1, Tara L Spires-Jones2, Rose Pitstick3, George A Carlson3, Amy M Pooler4, Bradley T Hyman5.
Abstract
In Alzheimer's disease and tauopathies, tau protein aggregates into neurofibrillary tangles that progressively spread to synaptically connected brain regions. A prion-like mechanism has been suggested: misfolded tau propagating through the brain seeds neurotoxic aggregation of soluble tau in recipient neurons. We use transgenic mice and viral tau expression to test the hypotheses that trans-synaptic tau propagation, aggregation, and toxicity rely on the presence of endogenous soluble tau. Surprisingly, mice expressing human P301Ltau in the entorhinal cortex showed equivalent tau propagation and accumulation in recipient neurons even in the absence of endogenous tau. We then tested whether the lack of endogenous tau protects against misfolded tau aggregation and toxicity, a second prion model paradigm for tau, using P301Ltau-overexpressing mice with severe tangle pathology and neurodegeneration. Crossed onto tau-null background, these mice had similar tangle numbers but were protected against neurotoxicity. Therefore, misfolded tau can propagate across neural systems without requisite templated misfolding, but the absence of endogenous tau markedly blunts toxicity. These results show that tau does not strictly classify as a prion protein.Entities:
Keywords: Alzheimer's disease; P301L tau; neurodegeneration; neurofibrillary tangles; prion‐like
Mesh:
Substances:
Year: 2015 PMID: 26538322 PMCID: PMC4687785 DOI: 10.15252/embj.201592748
Source DB: PubMed Journal: EMBO J ISSN: 0261-4189 Impact factor: 11.598